[Clinical signs of Cushing's syndrome after long-term local application of steroid in the oral cavity].
Topical glucocorticoids are the most commonly used drugs for treating a number of acute and chronic inflammatory diseases of the skin and the mucous membranes. Prolonged use of superpotent and potent topical glucocorticoids is related to an increased risk of developing severe side effects. In this case we describe the development of clinical signs of Cushing's syndrome in a 26-year-old woman, after continued daily application of potent topical glucocorticoid in the oral cavity.
Dermato-venerologisk Afdeling S, Aarhus Universitetshospital, Denmark. klings@yahoo.com
Kristina
K
Lings
Mette
M
Deleuran
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage; D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D003480:Cushing Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005756:Gastritis / Q000188:drug therapy; D006801:Humans; D017676:Lichen Planus, Oral / Q000188:drug therapy; D009061:Mouth Mucosa / Q000187:drug effects; D000077402:Pantoprazole
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D005446:Fluocinolone Acetonide; D000077402:Pantoprazole